Overview

Meclizine Plasma Levels in Responders and Non-responders

Status:
Not yet recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
Motion sickness is a debilitating condition that can effect many crew members. Meclizine has long been known as an effective anti motion sickness drug. The response to the drug is variable - some are responders, while others are resistant to the drug. The aim of the present study is to examine whether there is a correlation between meclizine plasma levels and clinical response.
Phase:
Phase 4
Details
Lead Sponsor:
Medical Corps, Israel Defense Force
Treatments:
Meclizine